Has held multiple GM roles in life science & aerospace companies. After monetizing his 1st startup thru a sale to Orthofix, he turned around Celleration, a VC backed company developing and then, commercializing a new technology in the wound care, tissue regeneration market. Under his leadership, technology was developed, FDA approved, clinically validated, obtained a unique CPTcode, dedicated reimbursement and achieved 4th yr sales of $10MM.

Has held positions in the Life Science market in marketing and R&D. After leaving Dacomed, he joined Medtronic’s Neurological Division to market spinal cord stimulation products for chronic pain and developed new therapeutic markets utilizing nerve stimulation. He co-founded RST in 2000, a privately held developer of an implanted medical device for implanted cell cultures and later, a wound barrier film leading to the patent applications.